401k Plan data: PHARMSCRIPT LLC 401K PLAN plan

PHARMSCRIPT LLC 401K PLAN 401k Plan overview

Plan Name	PHARMSCRIPT LLC 401K PLAN
Plan identification number	001

PHARMSCRIPT LLC 401K PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

PS INTERMEDIATE HOLDCO II, LLC has sponsored the creation of one or more 401k plans.

Company Name: PS INTERMEDIATE HOLDCO II, LLC

Employer identification number (EIN): 812306672

NAIC Classification: 446110
NAIC Description: Pharmacies and Drug Stores

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMSCRIPT LLC 401K PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2023-01-01
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 CHANA HOFF

Plan Statistics for PHARMSCRIPT LLC 401K PLAN

401k plan membership statisitcs for PHARMSCRIPT LLC 401K PLAN

Measure Date Value
2023: PHARMSCRIPT LLC 401K PLAN 2023 401k membership
Total participants, beginning-of-year 2023-01-01 2,032
Total number of active participants reported on line 7a of the Form 5500 2023-01-01 1,938
Number of retired or separated participants receiving benefits 2023-01-01 0
Number of other retired or separated participants entitled to future benefits 2023-01-01 98
Total of all active and inactive participants 2023-01-01 2,036
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2023-01-01 1
Total participants 2023-01-01 2,037
Number of participants with account balances 2023-01-01 925
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2023-01-01 27
2022: PHARMSCRIPT LLC 401K PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,739
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 1,867
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 110
Total of all active and inactive participants 2022-01-01 1,977
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 1,977
Number of participants with account balances 2022-01-01 979
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 45
2021: PHARMSCRIPT LLC 401K PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,659
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 1,609
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 76
Total of all active and inactive participants 2021-01-01 1,685
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 1,685
Number of participants with account balances 2021-01-01 613
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 36
2020: PHARMSCRIPT LLC 401K PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,487
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 1,648
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 32
Total of all active and inactive participants 2020-01-01 1,680
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 1
Total participants 2020-01-01 1,681
Number of participants with account balances 2020-01-01 568
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 29
2019: PHARMSCRIPT LLC 401K PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 1,059
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 1,172
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 39
Total of all active and inactive participants 2019-01-01 1,211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 1,211
Number of participants with account balances 2019-01-01 486
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 40
2018: PHARMSCRIPT LLC 401K PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 832
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 825
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 63
Total of all active and inactive participants 2018-01-01 888
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 888
Number of participants with account balances 2018-01-01 381
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 39
2017: PHARMSCRIPT LLC 401K PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 531
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 644
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 78
Total of all active and inactive participants 2017-01-01 722
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 722
Number of participants with account balances 2017-01-01 320
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 24

Measure	Date	Value
2023: PHARMSCRIPT LLC 401K PLAN 2023 401k membership
Total participants, beginning-of-year	2023-01-01	2,032
Total number of active participants reported on line 7a of the Form 5500	2023-01-01	1,938
Number of retired or separated participants receiving benefits	2023-01-01	0
Number of other retired or separated participants entitled to future benefits	2023-01-01	98
Total of all active and inactive participants	2023-01-01	2,036
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2023-01-01	1
Total participants	2023-01-01	2,037
Number of participants with account balances	2023-01-01	925
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2023-01-01	27
2022: PHARMSCRIPT LLC 401K PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,739
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	1,867
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	110
Total of all active and inactive participants	2022-01-01	1,977
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	1,977
Number of participants with account balances	2022-01-01	979
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	45
2021: PHARMSCRIPT LLC 401K PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,659
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	1,609
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	76
Total of all active and inactive participants	2021-01-01	1,685
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	1,685
Number of participants with account balances	2021-01-01	613
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	36
2020: PHARMSCRIPT LLC 401K PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,487
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	1,648
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	32
Total of all active and inactive participants	2020-01-01	1,680
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	1
Total participants	2020-01-01	1,681
Number of participants with account balances	2020-01-01	568
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	29
2019: PHARMSCRIPT LLC 401K PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	1,059
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	1,172
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	39
Total of all active and inactive participants	2019-01-01	1,211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	1,211
Number of participants with account balances	2019-01-01	486
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	40
2018: PHARMSCRIPT LLC 401K PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	832
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	825
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	63
Total of all active and inactive participants	2018-01-01	888
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	888
Number of participants with account balances	2018-01-01	381
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	39
2017: PHARMSCRIPT LLC 401K PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	531
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	644
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	78
Total of all active and inactive participants	2017-01-01	722
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	722
Number of participants with account balances	2017-01-01	320
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	24

Financial Data on PHARMSCRIPT LLC 401K PLAN

Measure	Date	Value
2023 : PHARMSCRIPT LLC 401K PLAN 2023 401k financial data
Total unrealized appreciation/depreciation of assets	2023-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Total income from all sources (including contributions)	2023-12-31	$8,224,181
Total loss/gain on sale of assets	2023-12-31	$0
Total of all expenses incurred	2023-12-31	$3,295,140
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2023-12-31	$2,898,546
Value of total corrective distributions	2023-12-31	$275,905
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2023-12-31	$4,497,230
Value of total assets at end of year	2023-12-31	$23,099,945
Value of total assets at beginning of year	2023-12-31	$18,170,904
Total of administrative expenses incurred including professional, contract, advisory and management fees	2023-12-31	$120,689
Total interest from all sources	2023-12-31	$12,703
Total dividends received (eg from common stock, registered investment company shares)	2023-12-31	$29,347
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2023-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2023-12-31	$29,347
Was this plan covered by a fidelity bond	2023-12-31	Yes
Value of fidelity bond cover	2023-12-31	$500,000
If this is an individual account plan, was there a blackout period	2023-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2023-12-31	No
Contributions received from participants	2023-12-31	$3,735,734
Participant contributions at end of year	2023-12-31	$485,389
Participant contributions at beginning of year	2023-12-31	$457,119
Income. Received or receivable in cash from other sources (including rollovers)	2023-12-31	$761,422
Other income not declared elsewhere	2023-12-31	$7
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Value of net income/loss	2023-12-31	$4,929,041
Value of net assets at end of year (total assets less liabilities)	2023-12-31	$23,099,945
Value of net assets at beginning of year (total assets less liabilities)	2023-12-31	$18,170,904
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2023-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2023-12-31	No
Were any leases to which the plan was party in default or uncollectible	2023-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2023-12-31	$1,900,073
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2023-12-31	$1,313,043
Value of interest in pooled separate accounts at end of year	2023-12-31	$20,271,512
Value of interest in pooled separate accounts at beginning of year	2023-12-31	$15,332,548
Interest on participant loans	2023-12-31	$5,993
Interest earned on other investments	2023-12-31	$6,710
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2023-12-31	$442,971
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2023-12-31	$430,905
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2023-12-31	$264,686
Net investment gain/loss from pooled separate accounts	2023-12-31	$3,420,208
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2023-12-31	No
Was there a failure to transmit to the plan any participant contributions	2023-12-31	No
Has the plan failed to provide any benefit when due under the plan	2023-12-31	No
Contributions received in cash from employer	2023-12-31	$74
Employer contributions (assets) at beginning of year	2023-12-31	$637,289
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2023-12-31	$2,898,546
Contract administrator fees	2023-12-31	$120,689
Did the plan have assets held for investment	2023-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2023-12-31	No
Opinion of an independent qualified public accountant for this plan	2023-12-31	Unqualified
Accountancy firm name	2023-12-31	GRANT THORNTON LLP
Accountancy firm EIN	2023-12-31	366055558
2022 : PHARMSCRIPT LLC 401K PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$2,669,874
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$2,337,531
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$2,008,625
Value of total corrective distributions	2022-12-31	$237,648
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$6,221,223
Value of total assets at end of year	2022-12-31	$18,170,904
Value of total assets at beginning of year	2022-12-31	$17,838,561
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$91,258
Total interest from all sources	2022-12-31	$12,097
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$18,634
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$18,634
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$3,586,022
Participant contributions at end of year	2022-12-31	$457,119
Participant contributions at beginning of year	2022-12-31	$316,181
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$1,979,979
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2022-12-31	$577
Other income not declared elsewhere	2022-12-31	$661
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$332,343
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$18,170,904
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$17,838,561
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$1,313,043
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$1,137,753
Value of interest in pooled separate accounts at end of year	2022-12-31	$15,332,548
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$15,611,033
Interest on participant loans	2022-12-31	$6,538
Interest earned on other investments	2022-12-31	$5,559
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$430,905
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$140,051
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-394,281
Net investment gain/loss from pooled separate accounts	2022-12-31	$-3,188,460
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$655,222
Employer contributions (assets) at end of year	2022-12-31	$637,289
Employer contributions (assets) at beginning of year	2022-12-31	$633,543
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$2,008,048
Contract administrator fees	2022-12-31	$91,258
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	GRANT THORNTON LLP
Accountancy firm EIN	2022-12-31	366055558
2021 : PHARMSCRIPT LLC 401K PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$143,087
Total income from all sources (including contributions)	2021-12-31	$6,595,542
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,244,320
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$994,119
Value of total corrective distributions	2021-12-31	$166,347
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$4,481,786
Value of total assets at end of year	2021-12-31	$17,838,561
Value of total assets at beginning of year	2021-12-31	$12,630,426
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$83,854
Total interest from all sources	2021-12-31	$8,951
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$13,996
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$13,996
Administrative expenses professional fees incurred	2021-12-31	$7,257
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$3,279,341
Participant contributions at end of year	2021-12-31	$316,181
Participant contributions at beginning of year	2021-12-31	$226,926
Participant contributions at beginning of year	2021-12-31	$19
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$568,902
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-12-31	$143,087
Other income not declared elsewhere	2021-12-31	$48
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$5,351,222
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$17,838,561
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$12,487,339
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$1,137,753
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$841,388
Value of interest in pooled separate accounts at end of year	2021-12-31	$15,611,033
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$10,821,678
Interest on participant loans	2021-12-31	$5,889
Interest earned on other investments	2021-12-31	$3,062
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$140,051
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$291,430
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$75,390
Net investment gain/loss from pooled separate accounts	2021-12-31	$2,015,371
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$633,543
Employer contributions (assets) at end of year	2021-12-31	$633,543
Employer contributions (assets) at beginning of year	2021-12-31	$448,985
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$994,119
Contract administrator fees	2021-12-31	$76,597
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	GRANT THORNTON LLP
Accountancy firm EIN	2021-12-31	366055558
2020 : PHARMSCRIPT LLC 401K PLAN 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$143,087
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$89,395
Expenses. Interest paid	2020-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$6,113,145
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$849,678
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$767,076
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$4,720,635
Value of total assets at end of year	2020-12-31	$12,630,426
Value of total assets at beginning of year	2020-12-31	$7,313,267
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$82,602
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$9,954
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$9,499
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$9,499
Administrative expenses professional fees incurred	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Amount of non-exempt transactions with any party-in-interest	2020-12-31	$0
Contributions received from participants	2020-12-31	$2,563,349
Participant contributions at end of year	2020-12-31	$226,926
Participant contributions at beginning of year	2020-12-31	$135,780
Participant contributions at end of year	2020-12-31	$19
Participant contributions at beginning of year	2020-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$1,708,301
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$2,301
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2020-12-31	$143,087
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$89,395
Other income not declared elsewhere	2020-12-31	$0
Administrative expenses (other) incurred	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Income. Non cash contributions	2020-12-31	$0
Value of net income/loss	2020-12-31	$5,263,467
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$12,487,339
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$7,223,872
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2020-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$841,388
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$5,897,230
Value of interest in pooled separate accounts at end of year	2020-12-31	$10,821,678
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$0
Interest on participant loans	2020-12-31	$6,779
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$3,175
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$837,053
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$837,053
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$291,430
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$-12,295
Net investment gain/loss from pooled separate accounts	2020-12-31	$1,385,352
Net investment gain or loss from common/collective trusts	2020-12-31	$0
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$448,985
Employer contributions (assets) at end of year	2020-12-31	$448,985
Employer contributions (assets) at beginning of year	2020-12-31	$443,204
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$764,775
Contract administrator fees	2020-12-31	$82,602
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	EISNERAMPER LLP
Accountancy firm EIN	2020-12-31	131639826
2019 : PHARMSCRIPT LLC 401K PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$89,395
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$3,193,878
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$387,316
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$307,193
Expenses. Certain deemed distributions of participant loans	2019-12-31	$6,688
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,318,766
Value of total assets at end of year	2019-12-31	$7,313,267
Value of total assets at beginning of year	2019-12-31	$4,417,310
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$73,435
Total interest from all sources	2019-12-31	$7,700
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$141,715
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$141,715
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,755,655
Participant contributions at end of year	2019-12-31	$135,780
Participant contributions at beginning of year	2019-12-31	$91,605
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$119,907
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2019-12-31	$89,395
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,806,562
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$7,223,872
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$4,417,310
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$5,897,230
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$3,466,002
Interest on participant loans	2019-12-31	$5,603
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$837,053
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$534,949
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$534,949
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$2,097
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$725,697
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$443,204
Employer contributions (assets) at end of year	2019-12-31	$443,204
Employer contributions (assets) at beginning of year	2019-12-31	$324,754
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$307,193
Contract administrator fees	2019-12-31	$73,435
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	EISNERAMPER LLP
Accountancy firm EIN	2019-12-31	131639826
2018 : PHARMSCRIPT LLC 401K PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,442,755
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$470,337
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$414,867
Expenses. Certain deemed distributions of participant loans	2018-12-31	$4,403
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,656,745
Value of total assets at end of year	2018-12-31	$4,417,310
Value of total assets at beginning of year	2018-12-31	$3,444,892
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$51,067
Total interest from all sources	2018-12-31	$5,693
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$83,567
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$83,567
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,272,896
Participant contributions at end of year	2018-12-31	$91,605
Participant contributions at beginning of year	2018-12-31	$65,286
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$59,095
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$972,418
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$4,417,310
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$3,444,892
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$3,466,002
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$2,507,284
Interest on participant loans	2018-12-31	$4,494
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$534,949
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$652,664
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$652,664
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$1,199
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-303,250
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$324,754
Employer contributions (assets) at end of year	2018-12-31	$324,754
Employer contributions (assets) at beginning of year	2018-12-31	$219,658
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$414,867
Contract administrator fees	2018-12-31	$51,067
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	FULLER LOWENBERG & CO., CPAS, P.C.
Accountancy firm EIN	2018-12-31	200066099
2017 : PHARMSCRIPT LLC 401K PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$3,377
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$1,805,871
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$115,534
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$82,211
Expenses. Certain deemed distributions of participant loans	2017-12-31	$512
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,543,701
Value of total assets at end of year	2017-12-31	$3,444,892
Value of total assets at beginning of year	2017-12-31	$1,751,178
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$32,811
Total interest from all sources	2017-12-31	$2,010
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$50,077
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$50,077
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$854,546
Participant contributions at end of year	2017-12-31	$65,286
Participant contributions at beginning of year	2017-12-31	$25,334
Participant contributions at end of year	2017-12-31	$0
Participant contributions at beginning of year	2017-12-31	$3,291
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$469,497
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$1,690,337
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$3,444,892
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$1,751,178
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$12,521
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$2,507,284
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$0
Interest on participant loans	2017-12-31	$1,743
Value of interest in common/collective trusts at end of year	2017-12-31	$0
Value of interest in common/collective trusts at beginning of year	2017-12-31	$1,059,729
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$652,664
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$517,937
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$517,937
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$267
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$210,083
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$219,658
Employer contributions (assets) at end of year	2017-12-31	$219,658
Employer contributions (assets) at beginning of year	2017-12-31	$144,887
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$82,211
Contract administrator fees	2017-12-31	$20,290
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	FULLER LOWENBERG & CO., CPAS, P.C.
Accountancy firm EIN	2017-12-31	200066099

Form 5500 Responses for PHARMSCRIPT LLC 401K PLAN

2023: PHARMSCRIPT LLC 401K PLAN 2023 form 5500 responses
2023-01-01	Type of plan entity	Single employer plan
2023-01-01	This submission is the final filing	No
2023-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2023-01-01	Plan is a collectively bargained plan	No
2023-01-01	Plan funding arrangement – Insurance	Yes
2023-01-01	Plan funding arrangement – Trust	Yes
2023-01-01	Plan benefit arrangement – Insurance	Yes
2023-01-01	Plan benefit arrangement - Trust	Yes
2022: PHARMSCRIPT LLC 401K PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: PHARMSCRIPT LLC 401K PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: PHARMSCRIPT LLC 401K PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: PHARMSCRIPT LLC 401K PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: PHARMSCRIPT LLC 401K PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: PHARMSCRIPT LLC 401K PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

724408

Policy instance

Insurance contract or identification number	724408
Number of Individuals Covered	2037
Insurance policy start date	2023-01-01
Insurance policy end date	2023-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

467968

Policy instance

Insurance contract or identification number	467968
Number of Individuals Covered	2037
Insurance policy start date	2023-01-01
Insurance policy end date	2023-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

724408

Policy instance

Insurance contract or identification number	724408
Number of Individuals Covered	1977
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $20,536
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $20,536
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

467968

Policy instance

Insurance contract or identification number	467968
Number of Individuals Covered	1977
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $342
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $342
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

724408

Policy instance

Insurance contract or identification number	724408
Number of Individuals Covered	1685
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $18,855
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $18,855
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

467968

Policy instance

Insurance contract or identification number	467968
Number of Individuals Covered	1685
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $333
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $333
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

724408

Policy instance

Insurance contract or identification number	724408
Number of Individuals Covered	1681
Insurance policy start date	2020-05-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $5,096
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $5,096
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

467968

Policy instance

Insurance contract or identification number	467968
Number of Individuals Covered	1681
Insurance policy start date	2020-05-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $182
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $182
Amount paid for insurance broker fees	0
Insurance broker organization code?	3

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	PS INTERMEDIATE HOLDCO II, LLC
Employer identification number (EIN):	812306672
NAIC Classification:	446110
NAIC Description:	Pharmacies and Drug Stores